Pediatric Oncology Group Studies

Vats, Trib Singh

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Cooperative Clinical Research--Cooperative Agreements (U10)
• Project #: 3U10CA028841-10S1
• Application #: 3556987
• Study Section: Cancer Clinical Investigation Review Committee (CCI)
• Project Start: 1981-01-01
• Project End: 1991-03-31
• Budget Start: 1990-01-01
• Budget End: 1991-03-31
• Support Year: 10
• Fiscal Year: 1991

Institution

• Name: University of Kansas
• Type: Schools of Medicine
• DUNS #: 016060860
• City: Kansas City
• State: KS
• Country: United States
• Zip Code: 66160

Publications

Whitehead, V M; Shuster, J J; Vuchich, M J et al. (2005) Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Leukemia 19:533-6

Crist, W; Shuster, J; Look, T et al. (1992) Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group. Leukemia 6 Suppl 2:162-6

Trueworthy, R; Shuster, J; Look, T et al. (1992) Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 10:606-13

Vats, T; Kamen, B; Krischer, J P (1991) Phase II trial of ICRF-187 in children with solid tumors and acute leukemia. Invest New Drugs 9:333-7

Whitehead, V M; Bernstein, M L; Vega, R et al. (1990) Phase I trial of indicine-N-oxide in children with leukemia and solid tumors: a Pediatric Oncology Group study. Cancer Chemother Pharmacol 26:377-9